Association of Hemoglobin Levels and Cognitive Function in Alzheimer's Disease and Mild Cognitive Impairment.
- Author:
Joon Kyung PARK
1
;
Kang Joon LEE
;
Hyun KIM
Author Information
1. Department of Psychiatry, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea. intuit@paik.ac.kr
- Publication Type:Original Article
- Keywords:
Hemoglobin levels;
Anemia;
Alzheimer's disease;
Mild cognitive impairment
- MeSH:
Adult;
Aged;
Alzheimer Disease*;
Anemia;
Biomarkers;
Chemistry;
Cognition Disorders;
Cognition*;
Dementia;
Hematocrit;
Humans;
Longitudinal Studies;
Mild Cognitive Impairment*;
Prospective Studies;
Risk Factors
- From:Korean Journal of Psychosomatic Medicine
2016;24(1):94-101
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVES: Anemia is a common problem in the management of elderly patients. Recent studies reported that anemia was associated with cognitive impairment and Alzheimer's disease. This study was aimed to analyze the differences of hemoglobin levels in Korean patients with Alzheimer's disease(AD) dementia, mild cognitive impairment(MCI), and healthy controls. Furthermore, the study also examined if any association between hemoglobin levels and cognitive functions existed. METHODS: A total of 116 Korean elderly adults were participated in this study(mean age 74.67 years ; 60.3% female). The Korean version of the Mini-Mental State Examination(MMSE-K), Clinical Dementia Rating(CDR) and Global Deterioration Scale(GDS) were applied to all subjects. Hematological and related blood chemistry values were investigated. RESULTS: We found that patients with AD dementia had significantly lower hemoglobin and hematocrit levels than MCI subjects and healthy control group. The hemoglobin levels showed a positive correlation with MMSE-K and negative correlation with CDR, GDS. CONCLUSIONS: Among Korean elderly, low hemoglobin level is associated with a cognitive impairment. This study indicates that AD is associated with anemia, and low hemoglobin levels may contribute to potentially useful clinical markers of AD. The risk factor for dementia needs to be confirmed by prospective longitudinal studies in a larger group of patients.
